Last Updated: November 9, 2026

Details for Patent: 7,498,440

Name: Drug Patent Intelligence for US Patent 7498440
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

« Back to Dashboard

Summary for Patent: 7,498,440

Title:	Muscarinic acetylcholine receptor antagonists
Abstract:	Muscarinic Acetylcholine Receptor Antagonists and methods of using them are provided.
Inventor(s):	Damane I. Laine, Michael R. Palovich, Brent W. McCleland, Christopher E. Neipp, Sonia M. Thomas
Assignee:	Glaxo Group Ltd
Application Number:	US11/568,330
Patent Claim Types: see list of patent claims	Composition; Compound; Delivery;

Drugs Protected by US Patent 7,498,440

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 7,498,440

PCT Information
PCT Filed	April 27, 2005	PCT Application Number:	PCT/US2005/014386
PCT Publication Date:	November 10, 2005	PCT Publication Number:	WO2005/104745

International Family Members for US Patent 7,498,440

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
European Patent Office	1740177	⤷ Start Trial	C300694	Netherlands	⤷ Start Trial
European Patent Office	1740177	⤷ Start Trial	CA 2014 00052	Denmark	⤷ Start Trial
European Patent Office	1740177	⤷ Start Trial	PA2014038	Lithuania	⤷ Start Trial
European Patent Office	1740177	⤷ Start Trial	92565	Luxembourg	⤷ Start Trial
European Patent Office	1740177	⤷ Start Trial	1490060-9	Sweden	⤷ Start Trial
European Patent Office	1740177	⤷ Start Trial	14C0075	France	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.